Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Supporting Information 4: 435 articles exclusion: 1. Alagusundaramoorthy SS, Gedaly R. Role of surgery and transplantation in the treatment of hepatic metastases from neuroendocrine tumor. World journal of gastroenterology : WJG. 2014;20:14348-14358. 2. Bhalla A, Sandhu F, Sieber S. Primary adrenal leiomyosarcoma: a case report and review of the literature. Connecticut medicine. 2014;78:403-407. 3. Chung H, Chapman WC. Liver transplantation for metastatic neuroendocrine tumors. Advances in surgery. 2014;48:235-252. 4. Clark ME, Smith RR. Liver-directed therapies in metastatic colorectal cancer. Journal of gastrointestinal oncology. 2014;5:374-387. 5. D'Haese JG, Tosolini C, Ceyhan GO, et al. Update on surgical treatment of pancreatic neuroendocrine neoplasms. World journal of gastroenterology : WJG. 2014;20:13893-13898. 6. Hori T, Takaori K, Uemoto S. Pancreatic neuroendocrine tumor accompanied with multiple liver metastases. World journal of hepatology. 2014;6:596-600. 7. Kolbeck KJ, Farsad K. Catheter-based treatments for hepatic metastases from neuroendocrine tumors. AJR. American journal of roentgenology. 2014;203:717-724. 8. Kopljar M, Patrlj L, Busic Z, et al. Potential use of Doppler perfusion index in detection of occult liver metastases from colorectal cancer. Hepatobiliary surgery and nutrition. 2014;3:259-267. 9. Lahat E, Eshkenazy R, Zendel A, et al. Complications after percutaneous ablation of liver tumors: a systematic review. Hepatobiliary surgery and nutrition. 2014;3:317-323. 10. Magata H, Kondo K, Otani K, et al. [A case of long-term survival after low-dose FP systemic chemotherapy for a tumor thrombus in the inferior caval vein and multiple lung metastases from recurrent hepatocellular carcinoma]. Gan to kagaku ryoho. Cancer & chemotherapy. 2014;41:1147-1150. 11. Nigri G, Petrucciani N, Ferla F, La Torre M, Aurello P, Ramacciato G. Neoadjuvant chemotherapy for resectable colorectal liver metastases: What is the evidence? Results of a systematic review of comparative studies. The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland. 2014. 12. Park J, Chen YJ, Lu WP, Fong Y. The Evolution of Liver-Directed Treatments for Hepatic Colorectal Metastases. Oncology (Williston Park, N.Y.). 2014;28. 13. Patrlj L, Kopljar M, Klicek R, et al. The surgical treatment of patients with colorectal cancer and liver metastases in the setting of the "liver first" approach. Hepatobiliary surgery and nutrition. 2014;3:324-329. 14. Rossi RE, Massironi S, Conte D, Peracchi M. Therapy for metastatic pancreatic neuroendocrine tumors. Annals of translational medicine. 2014;2:8. 15. Treasure T, Milosevic M, Fiorentino F, Pfannschmidt J. History and present status of pulmonary metastasectomy in colorectal cancer. World journal of gastroenterology : WJG. 2014;20:14517-14526. 16. Wei IH, Healy MA, Wong SL. Surgical treatment options for stage IV melanoma. The Surgical clinics of North America. 2014;94:1075-1089, ix. 17. Zendel A, Lahat E, Dreznik Y, Zakai BB, Eshkenazy R, Ariche A. "Vanishing liver metastases"-A real challenge for liver surgeons. Hepatobiliary surgery and nutrition. 2014;3:295-302. 18. Farmer RG. Preoperative preparation of the patients with carcinoma of the colon. The Surgical clinics of North America. 1975;55:1335-1341. 19. Goldring J, McNaught W, Scott A, Gillespie G. Prophylactic oral antimicrobial agents in elective colonic surgery. A controlled trial. Lancet. 1975;2:997-1000. 20. Bruckner R, Kempf P, Kutzner J, Brunner H. [Preliminary results of preoperative radiotherapy in carcinoma of the rectum (author's transl)]. Deutsche medizinische Wochenschrift (1946). 1977;102:195-198. 21. Kligerman MM. Radiotherapy and rectal cancer. Cancer. 1977;39:896-900. 22. Taylor I, Brooman P, Rowling JT. Adjuvant liver perfusion in colorectal cancer: initial results of a clinical trial. British medical journal. 1977;2:1320-1322. 23. Yura J, Kato F, Shibata K. Postoperative infections in colorectal surgery. International surgery. 1978;63:61-62. 24. Keighley MR, Arabi Y, Alexander-Williams J, Youngs D, Burdon DW. Comparison between systemic and oral antimicrobial prophylaxis in colorectal surgery. Lancet. 1979;1:894-897. 25. Molin K, Rieger A. Effect of preoperative oral administration of oxytetracycline and neomycin on postoperative infectious complications in cases of cancer coli-recti. Acta chirurgica Scandinavica. 1979;145:177-183. 26. Taylor I, Rowling J, West C. Adjuvant cytotoxic liver perfusion for colorectal cancer. The British journal of surgery. 1979;66:833-837. 27. Terranova O, Sandei F, Rebuffat C, Maruotti R, Pezzuoli G. Management of the perineal wound after rectal excision for neoplastic disease: a controlled clinical trial. Diseases of the colon and rectum. 1979;22:228-233. 28. Bolton RA, Britton DC. Restorative surgery of the rectum with a circumferential stapler. Lancet. 1980;1:850-851. 29. Nilsson E, Lamke LO, Liljedahl SO, Elfstrom K. Is albumin therapy worthwhile in surgery for colorectal cancer? Acta chirurgica Scandinavica. 1980;146:619-622. 30. Aeberhard P, Fluckiger M, Berger J, Novak A. [Parenteral antibiotic prophylaxis or oral antimicrobial bowel preparation for colorectal surgery (author's transl)]. Langenbecks Archiv fur Chirurgie. 1981;353:233-240. 31. Oberst MT, Graham D, Geller NL, Stearns MW, Jr., Tiernan E. Catheter management programs and postoperative urinary dysfunction. Research in nursing & health. 1981;4:175-181. 32. Balslev I, Pedersen M, Teglbjaerg PS, et al. Postoperative radiotherapy in rectosigmoid cancer Dukes' B and C: interim report from a randomized multicentre study. British journal of cancer. 1982;46:551-556. 33. Finlay IG, Meek DR, Gray HW, Duncan JG, McArdle CS. Incidence and detection of occult hepatic metastases in colorectal carcinoma. British medical journal (Clinical research ed.). 1982;284:803-805. 34. Steele G, Jr., Ellenberg S, Ramming K, et al. CEA monitoring among patients in multi-institutional adjuvant G.I. therapy protocols. Annals of surgery. 1982;196:162-169. 35. Graffner H, Fredlund P, Olsson SA, Oscarson J, Petersson BG. Protective colostomy in low anterior resection of the rectum using the EEA stapling instrument. A randomized study. Diseases of the colon and rectum. 1983;26:87-90. 36. Knysh VI, Aliev BM, Barsukov Iu A. [Combination treatment of rectal cancer using 2 variants of preoperative concentration gamma therapy]. Meditsinskaia radiologiia. 1983;28:12-17. 37. Roth E, Funovics J, Karner J, Huk I, Schulz F, Fritsch A. [Lack of stimulation of nitrogen retention and plasma protein synthesis due to increased intake of branched-chain amino acids]. Infusionstherapie und klinische Ernahrung. 1983;10:259-266. 38. Bauer E, Graber R, Brodtke R, Lunstedt B, Seifert J. [Nutrition physiologic, immunologic and clinical parameters in prospective randomized patients by enteral or parenteral nutrition therapy following large intestine operations]. Infusionstherapie und klinische Ernahrung. 1984;11:165-167. 39. Boulis-Wassif S, Gerard A, Loygue J, Camelot D, Buyse M, Duez N. Final results of a randomized trial on the treatment of rectal cancer with preoperative radiotherapy alone or in combination with 5-fluorouracil, followed by radical surgery. Trial of the European Organization on Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group. Cancer. 1984;53:1811-1818. 40. Cummings BJ. Adjuvant radiation therapy for rectal adenocarcinoma. Diseases of the colon and rectum. 1984;27:826-836. 41. Higgins GA, Donaldson RC, Rogers LS, Juler GL, Keehn RJ. Efficacy of MER immunotherapy when added to a regimen of 5-fluorouracil and methyl-CCNU following resection for carcinoma of the large bowel. A Veterans Administration Surgical Oncology Group report. Cancer. 1984;54:193-198. 42. Knysh VI, Aliev BM, Bondar GV, Dvoirin VV, Barsukov Iu A. [Effectiveness of combined and complex treatment of patients with operable cancer of the rectum]. Voprosy onkologii. 1984;30:42-48. 43. Kujath P, Bruch HP, Schmidt E, Doll W. [Perioperative prophylaxis in elective colorectal surgery]. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen. 1984;55:519-522. 44. Lohr J, Wagner PK, Rothmund M. [Perioperative antibiotic prophylaxis (single or multiple dose) in elective colorectal surgery. A randomized study]. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen. 1984;55:512-514. 45. Taylor RH, Gilbert JM, Evans MG, Lane HG, Cassell PG. Prospective serial liver ultrasound scanning in resectable colorectal cancer treated with adjuvant razoxane. Clinical & experimental metastasis. 1984;2:321-331. 46. Wacha H, Probst M. [Healing of the sacral wound cavity after abdomino-perineal extirpation of the rectum. A prospective randomized study using metronidazole]. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen. 1984;55:29-31. 47. Athanasiadis S, Kuhlgatz C, Hahnel E. [Perioperative antibiotic prevention in colon and rectum surgery. A randomized study on the value of single dose prevention]. Zentralblatt fur Chirurgie. 1985;110:532-538. 48. Cedermark B, Theve NO, Rieger A, et al. Preoperative short-term radiotherapy in rectal carcinoma. A preliminary report of a prospective randomized study. Cancer. 1985;55:1182-1185. 49. Duus BR, Philipsen T, Christensen JD, Lundvall F, Sondergaard J. Refractory condylomata acuminata: a controlled clinical trial of carbon dioxide laser versus conventional surgical treatment. Genitourinary medicine. 1985;61:59-61. 50. Fleites RA, Marshall JB, Eckhauser ML, Mansour EG, Imbembo AL, McCullough AJ. The efficacy of polyethylene glycol-electrolyte lavage solution versus traditional mechanical bowel preparation for elective colonic surgery: a randomized, prospective, blinded clinical trial. Surgery. 1985;98:708-717. 51. Jacobsen MB, Sorensen B, Melsom M, Aspestrand F, Andersen J. [Postoperative control of patients operated on for colonic cancer. A comparative study of coloscopy and double contrast radiography]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. 1985;105:742-743. 52. Pahlman L, Glimelius B, Graffman S. Pre- versus postoperative radiotherapy in rectal carcinoma: an interim report from a randomized multicentre trial. The British journal of surgery. 1985;72:961-966. 53. Parker MC, Ashby EC, Nicholls MW, Dowding CH, Brookes JC. Povidone-iodine bowel irrigation before resection of colorectal carcinoma. Annals of the Royal College of Surgeons of England. 1985;67:227-228. 54. Winkler R. [Adjuvant radiotherapy in rectosigmoid cancers]. Zentralblatt fur Chirurgie. 1985;110:124-136. 55. Balslev I, Pedersen M, Teglbjaerg PS, et al. Postoperative radiotherapy in Dukes' B and C carcinoma of the rectum and rectosigmoid. A randomized multicenter study. Cancer. 1986;58:22-28. 56. Fujimoto M, Sakai K, Ueda T. [Significance of amikacin administered orally prior to operation for prevention of postoperative infections in colonic cancer surgery]. The Japanese journal of antibiotics. 1986;39:2889-2896. 57. Higgins GA, Humphrey EW, Dwight RW, Roswit B, Lee LE, Jr., Keehn RJ. Preoperative radiation and surgery for cancer of the rectum. Veterans Administration Surgical Oncology Group Trial II. Cancer. 1986;58:352-359. 58. Kingston RD, Duthie J. Serious postoperative bleeding associated with a single intravenous dose of cefuroxime and metronidazole. The Journal of hospital infection. 1986;7:100-101. 59. Nakazato H, Ichihashi H, Kondo T. [Clinical results of a randomized controlled trial on the effect of adjuvant immunochemotherapy using Esquinon and Krestin in patients with curatively resected gastric cancer. Cooperative Study Group of Cancer Immunochemotherapy, Tokai Gastrointestinal Oncology Group]. Gan to kagaku ryoho. Cancer & chemotherapy. 1986;13:308-318. 60. Short-term preoperative radiotherapy for adenocarcinoma of the rectum. An interim analysis of a randomized multicenter trial. Stockholm Rectal Cancer Study Group. American journal of clinical oncology. 1987;10:369-375. 61. Abdel-Nabi HH, Schwartz AN, Higano CS, Wechter DG, Unger MW. Colorectal carcinoma: detection with indium-111 anticarcinoembryonic-antigen monoclonal antibody ZCE-025. Radiology. 1987;164:617-621. 62. Adalsteinsson B, Pahlman L, Hemmingsson A, Glimelius B, Graffman S. Computed tomography in early diagnosis of local recurrence of rectal carcinoma. Acta radiologica (Stockholm, Sweden : 1987). 1987;28:41-47. 63. Fasth S, Hulten L, Magnusson O, Nordgren S, Warnold I. The immediate and long-term effects of postoperative total parenteral nutrition on body composition. International journal of colorectal disease. 1987;2:139-145. 64. Fasth S, Hulten L, Magnusson O, Nordgren S, Warnold I. Postoperative complications in colorectal surgery in relation to preoperative clinical and nutritional state and postoperative nutritional treatment. International journal of colorectal disease. 1987;2:87-92. 65. Hallerback B, Carlsen E, Carlsson K, et al. Beta-adrenoceptor blockade in the treatment of postoperative adynamic ileus. Scandinavian journal of gastroenterology. 1987;22:149-155. 66. Racette DL, Chang FC, Trekell ME, Farha GJ. Is nasogastric intubation necessary in colon operations? American journal of surgery. 1987;154:640-642. 67. Windle R, Bell PR, Shaw D. Five year results of a randomized trial of adjuvant 5-fluorouracil and levamisole in colorectal cancer. The British journal of surgery. 1987;74:569-572. 68. Zilli L, Pietroiusti M, Bertario L. Colonoscopy in ostomy patients. Results at the first postoperative examination. Diseases of the colon and rectum. 1987;30:687-691. 69. Balslev I, Pedersen M, Teglbjaerg PS, et al. [Postoperative radiotherapy in cancer of the rectum and rectosigmoid. A prospective randomized multicenter study]. Ugeskrift for laeger. 1988;150:1958-1961. 70. Buess G, Kipfmuller K, Ibald R, et al. Clinical results of transanal endoscopic microsurgery. Surgical endoscopy. 1988;2:245-250. 71. Chlebowski RT, Nystrom S, Reynolds R, Weiner JM, Bateman JR. Long-term survival following levamisole or placebo adjuvant treatment of colorectal cancer: a Western Cancer Study Group Trial. Oncology. 1988;45:141-143. 72. Coppa GF, Eng K. Factors involved in antibiotic selection in elective colon and rectal surgery. Surgery. 1988;104:853-858. 73. Grundmann R, Weber F, Kluger J, Wienand P, Pulverer G. [Preoperative nonspecific immunostimulation with Propionibacterium granulosum KP-45 in patients with colorectal cancer. A prospective randomized study]. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen. 1988;59:272-278. 74. Kikuchi K, Shimizu H. [Clinical study of postoperative infection of gastrointestinal cancer. Randomized study of preventive efficacy of cefmetazole versus cephalothin in postoperative infection of gastric and colorectal cancer]. The Japanese journal of antibiotics. 1988;41:1480-1492. 75. Lau WY, Chu KW, Poon GP, Ho KK. Prophylactic antibiotics in elective colorectal surgery. The British journal of surgery. 1988;75:782-785. 76. Petrelli NJ, Conte CC, Herrera L, Stulc J, O'Neill P. A prospective, randomized trial of perioperative prophylactic cefamandole in elective colorectal surgery for malignancy. Diseases of the colon and rectum. 1988;31:427-429. 77. Vara-Thorbeck R, Rosell J, Salvi M, Vara-Thorbeck C. [Preoperative hemodilution for the prevention of postoperative deep venous thrombosis and early infectious complications in colorectal resections]. Zentralblatt fur Chirurgie. 1988;113:1204-1209. 78. Wiggers T, Jeekel J, Arends JW, et al. No-touch isolation technique in colon cancer: a controlled prospective trial. The British journal of surgery. 1988;75:409-415. 79. Bittner R, Butters M, Rampf W, Kapfer X. [Duration of the preventive use of antibiotics in colorectal surgery--single administration versus short-term prevention]. Langenbecks Archiv fur Chirurgie. 1989;374:272-279. 80. Fielding LP, Phillips RK, Hittinger R. Factors influencing mortality after curative resection for large bowel cancer in elderly patients. Lancet. 1989;1:595-597. 81. Jauch KW, Gunther B, Wicklmayr M, Dietze GJ, Schrofel L. Bradykinin infusion in long term postoperative parenteral nutrition improves nitrogen balance and protein synthesis. Advances in experimental medicine and biology. 1989;247A:581-585. 82. Mertes N, Pfisterer M, Winde G, et al. [Protein oriented peripheral venous nutrition following surgical trauma]. Infusionstherapie (Basel, Switzerland). 1989;16:60-66. 83. Mitomi T, Tsuchiya S, Iijima N, et al. [Randomized controlled study on adjuvant immunochemotherapy with PSK in curatively resected colorectal cancer. The Cooperative Study Group of Surgical Adjuvant Immunochemotherapy for Cancer of Colon and Rectum]. Gan to kagaku ryoho. Cancer & chemotherapy. 1989;16:2241-2249. 84. Stehle P, Zander J, Mertes N, et al. Effect of parenteral glutamine peptide supplements on muscle glutamine loss and nitrogen balance after major surgery. Lancet. 1989;1:231-233. 85. Preoperative short-term radiation therapy in operable rectal carcinoma. A prospective randomized trial. Stockholm Rectal Cancer Study Group. Cancer. 1990;66:49-55. 86. Alberts DS, Einspahr J, Rees-McGee S, et al. Effects of dietary wheat bran fiber on rectal epithelial cell proliferation in patients with resection for colorectal cancers. Journal of the National Cancer Institute. 1990;82:1280-1285. 87. Beart RW, Jr., Moertel CG, Wieand HS, et al. Adjuvant therapy for resectable colorectal carcinoma with fluorouracil administered by portal vein infusion. A study of the Mayo Clinic and the North Central Cancer Treatment Group. Archives of surgery (Chicago, Ill. : 1960). 1990;125:897-901. 88. Braga M, Baccari P, Di Palo S, et al. Effectiveness of perioperative short-term antibiotic prophylaxis in reducing surgical risk induced by malnutrition and anergy. Acta chirurgica Scandinavica. 1990;156:751-757. 89. Burke ER, Welvaart K. Complications of stapled anastomoses in anterior resection for rectal carcinoma: colorectal anastomosis versus coloanal anastomosis. Journal of surgical oncology. 1990;45:180-183. 90. Butters M, Miller W, Bittner R. [Effect of enteral and parenteral nutrition on glucose tolerance in the early postoperative phase]. Infusionstherapie (Basel, Switzerland). 1990;17:257-260. 91. Harju E, Huttunen J, Yla-Herttuala S. Clinical and metabolic effects and wound healing metabolism in controlled total parenteral nutrition with high vs. low nitrogen content for seven days after abdominoperineal rectum resection for carcinoma. Chirurgia italiana. 1990;42:151-164. 92. Horn A, Morild I, Dahl O. Tumour shrinkage and down staging after preoperative radiation of rectal adenocarcinomas. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 1990;18:19-28. 93. Knysh VI, Bondar GV, Barsukov Iu A, Timofeev Iu M, Basheev V. [Combined treatment of rectal cancer using intensive macrofractional preoperative irradiation]. Khirurgiia. 1990:53-57. 94. Lehner B, Schlag P, Liebrich W, Schirrmacher V. Postoperative active specific immunization in curatively resected colorectal cancer patients with a virus-modified autologous tumor cell vaccine. Cancer immunology, immunotherapy : CII. 1990;32:173-178. 95. Loser C, Folsch UR, Paprotny C, Creutzfeldt W. Polyamines in human gastrointestinal malignancies. Digestion. 1990;46 Suppl 2:430-438. 96. Moertel CG, Fleming TR, Macdonald JS, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. The New England journal of medicine. 1990;322:352-358. 97. Nikolov K. [The postoperative changes in the cellular immune response in vivo in patients with colorectal carcinoma after preoperative acute normovolemic hemodilution--a randomized, prospective and comparative study]. Khirurgiia. 1990;43:25-30. 98. Nikolov K, Videlov D, Lazarov S, Kalcheva V, Atanasov A. [A modified technic of preoperative acute normovolemic hemodilution--the advantages and economic effect of its use in planned colorectal surgery]. Khirurgiia. 1990;43:30-37. 99. Pahlman L, Glimelius B. Pre- or postoperative radiotherapy in rectal and rectosigmoid carcinoma. Report from a randomized multicenter trial. Annals of surgery. 1990;211:187-195. 100. Peters KM, Bornhofen B, Grundmann R, et al. [Neopterin as a marker of aspecific immunostimulation with Propionibacterium avidum KP-40 in patients with gastrointestinal tumors. A prospective randomized study]. Medizinische Klinik (Munich, Germany : 1983). 1990;85:421-424. 101. Rosenthal SA, Trock BJ, Coia LR. Randomized trials of adjuvant radiation therapy for rectal carcinoma: a review. Diseases of the colon and rectum. 1990;33:335-343. 102. Rouffet F, Mathon C, Vendroux J. [Extend of colonic excision in the curative treatment of cancers of the left colon. Left or segmental hemicolectomy? A controlled prospective multicenter study]. Chirurgie; memoires de l'Academie de chirurgie. 1990;116:419-423; discussion 424. 103. Scheele J, Stangl R, Altendorf-Hofmann A. Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. The British journal of surgery. 1990;77:1241-1246. 104. Schlag P, Hohenberger P, Herfarth C. Resection of liver metastases in colorectal cancer--competitive analysis of treatment results in synchronous versus metachronous metastases. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 1990;16:360-365. 105. Thirlby RC. Preoperative radiotherapy is better than postoperative radiotherapy in patients with rectal cancer. Gastroenterology. 1990;99:895-897. 106. Wereldsma JC, Bruggink ED, Meijer WS, Roukema JA, van Putten WL. Adjuvant portal liver infusion in colorectal cancer with 5-fluorouracil/heparin versus urokinase versus control. Results of a prospective randomized clinical trial (colorectal adenocarcinoma trial I). Cancer. 1990;65:425-432. 107. Becker JM, Alexander DP. Colectomy, mucosal proctectomy, and ileal pouch-anal anastomosis. A prospective trial of optimal antibiotic management. Annals of surgery. 1991;213:242-247. 108. Carli F, Webster J, Pearson M, et al. Postoperative protein metabolism: effect of nursing elderly patients for 24 h after abdominal surgery in a thermoneutral environment. British journal of anaesthesia. 1991;66:292-299. 109. Daly L. The first international urokinase/warfarin trial in colorectal cancer. Clinical & experimental metastasis. 1991;9:3-11. 110. Herbert SH, Curran WJ, Jr., Solin LJ, Stafford PM, Lanciano RM, Hanks GE. Decreasing gastrointestinal morbidity with the use of small bowel contrast during treatment planning for pelvic irradiation. International journal of radiation oncology, biology, physics. 1991;20:835-842. 111. James RD, Haboubi N, Schofield PF, Mellor M, Salhab N. Prognostic factors in colorectal carcinoma treated by preoperative radiotherapy and immediate surgery. Diseases of the colon and rectum. 1991;34:546-551. 112. Marks G, Mohiuddin M, Eitan A, Masoni L, Rakinic J. High-dose preoperative radiation and radical sphincter-preserving surgery for rectal cancer. Archives of surgery (Chicago, Ill. : 1960). 1991;126:1534-1540. 113. Mutch RS, Hutson PR. Levamisole in the adjuvant treatment of colon cancer. Clinical pharmacy. 1991;10:95-109. 114. Rosen HR, Marczell AP, Czerwenka E, Stierer MO, Spoula H, Wasl H. Local gentamicin application for perineal wound healing following abdominoperineal rectum excision. American journal of surgery. 1991;162:438-441. 115. Steele G, Jr., Bleday R, Mayer RJ, Lindblad A, Petrelli N, Weaver D. A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: Gastrointestinal Tumor Study Group Protocol 6584. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1991;9:1105-1112. 116. Treurniet-Donker AD, van Putten WL, Wereldsma JC, et al. Postoperative radiation therapy for rectal cancer. An interim analysis of a prospective, randomized multicenter trial in The Netherlands. Cancer. 1991;67:2042-2048. 117. Yamaguchi A, Ishida T, Nishimura G, et al. Detection by CT during arterial portography of colorectal cancer metastases to liver. Diseases of the colon and rectum. 1991;34:37-40. 118. Radiation therapy and fluorouracil with or without semustine for the treatment of patients with surgical adjuvant adenocarcinoma of the rectum. Gastrointestinal Tumor Study Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1992;10:549-557. 119. Arnaud JP, Bellissant E, Boissel P, et al. Single-dose amoxycillin-clavulanic acid vs. cefotetan for prophylaxis in elective colorectal surgery: a multicentre, prospective, randomized study. The PRODIGE Group. The Journal of hospital infection. 1992;22 Suppl A:23-32. 120. Bentzen SM, Balslev I, Pedersen M, et al. Time to loco-regional recurrence after resection of Dukes' B and C colorectal cancer with or without adjuvant postoperative radiotherapy. A multivariate regression analysis. British journal of cancer. 1992;65:102-107. 121. Braga M, Di Francesco A, Gianotti L, Baccari P, Di Carlo V. [Perioperative administration of thymopentin for the prevention of infections in oncologic surgery]. Minerva chirurgica. 1992;47:125-130. 122. Brivio F, Lissoni P, Tisi E, et al. Effects of a preoperative therapy with interleukin-2 on surgery-induced lymphocytopenia in cancer patients. Oncology. 1992;49:215-218. 123. Buess G, Mentges B, Manncke K, Starlinger M, Becker HD. Technique and results of transanal endoscopic microsurgery in early rectal cancer. American journal of surgery. 1992;163:63-69; discussion 69-70. 124. Cafiero F, Gipponi M, Bonalumi U, Piccardo A, Sguotti C, Corbetta G. Prophylaxis of infection with intravenous immunoglobulins plus antibiotic for patients at risk for sepsis undergoing surgery for colorectal cancer: results of a randomized, multicenter clinical trial. Surgery. 1992;112:24-31. 125. Cohen Z, McLeod RS, Stephen W, Stern HS, O'Connor B, Reznick R. Continuing evolution of the pelvic pouch procedure. Annals of surgery. 1992;216:506-511; discussion 511-502. 126. Coucke PA. Postoperative radiation therapy for rectal cancer: an interim analysis of a prospective, randomized multicenter trial in The Netherlands. Cancer. 1992;69:3016-3017. 127. Folli S, Wagnieres G, Pelegrin A, et al. Immunophotodiagnosis of colon carcinomas in patients injected with fluoresceinated chimeric antibodies against carcinoembryonic antigen. Proceedings of the National Academy of Sciences of the United States of America. 1992;89:7973-7977. 128. Hermanek P. [Multivisceral resection of colorectal cancer--experiences of the Colorectal Cancer Study Group]. Langenbecks Archiv fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft fur Chirurgie. Kongress. 1992:95-100. 129. Hofstad B, Vatn M, Hoff G, Larsen S, Osnes M. Growth of colorectal polyps: design of a prospective, randomized, placebo-controlled intervention study in patients with colorectal polyps. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP). 1992;1:415-422. 130. Hoynck van Papendrecht MA, Hop W, Langenhorst BL, Kothe FC, Marquet RL, Jeekel J. Feasibility of a predeposit autologous blood donation program in colorectal cancer patients: results from a randomized clinical study. Vox sanguinis. 1992;62:102-107. 131. Kuroda M, Inamura K, Tahara S, et al. Report of a study using phantom materials, and clinical experience with simultaneous radio-hyperthermotherapy. Acta medica Okayama. 1992;46:417-426. 132. Liu T, Liu Y, He S, Zhang Z, Kligerman MM. Use of radiation with or without WR-2721 in advanced rectal cancer. Cancer. 1992;69:2820-2825. 133. Lohde E, Scholz L, Gemperle A, et al. [Comparative analysis of mezlocillin/metronidazole and amoxicillin/clavulanic acid as "one shot" preventive antibiotic administration in colorectal interventions]. Zentralblatt fur Chirurgie. 1992;117:325-330. 134. Lumley JW, Siu SK, Pillay SP, et al. Single dose ceftriaxone as prophylaxis for sepsis in colorectal surgery. The Australian and New Zealand journal of surgery. 1992;62:292-296. 135. Mendenhall WM, Bland KI, Copeland EM, 3rd, et al. Does preoperative radiation therapy enhance the probability of local control and survival in high-risk distal rectal cancer? Annals of surgery. 1992;215:696-705; discussion 705-696. 136. Mitomi T, Tsuchiya S, Iijima N, et al. Randomized, controlled study on adjuvant immunochemotherapy with PSK in curatively resected colorectal cancer. The Cooperative Study Group of Surgical Adjuvant Immunochemotherapy for Cancer of Colon and Rectum (Kanagawa). Diseases of the colon and rectum. 1992;35:123-130. 137. Nichols PH, Ramsden CW, Ward U, Sedman PC, Primrose JN. Perioperative immunotherapy with recombinant interleukin 2 in patients undergoing surgery for colorectal cancer. Cancer research. 1992;52:5765-5769. 138. Poortmans PM, Hamers HP. Postoperative radiation therapy for rectal cancer: an interim analysis of a prospective, randomized multicenter trial in The Netherlands. Cancer. 1992;69:3017-3019. 139. Riwar A, Schar B, Grotzinger U. [Effect of continuous postoperative analgesia with peridural bupivacaine on intestinal motility following colorectal resection]. Helvetica chirurgica acta. 1992;58:729-733. 140. Rosenthal SA, Yeung RS, Weese JL, et al. Conservative management of extensive low-lying rectal carcinomas with transanal local excision and combined preoperative and postoperative radiation therapy. A report of a phase I-II trial. Cancer. 1992;69:335-341. 141. Shoji Y, Kusunoki M, Fujita S, Yamamura T, Utsunomiya J. Functional role of the preserved rectal cuff in ileoanal anastomosis. Surgery. 1992;111:266-273. 142. van Ooijen B, Wiggers T, Meijer S, et al. Hepatic resections for colorectal metastases in The Netherlands. A multiinstitutional 10-year study. Cancer. 1992;70:28-34. 143. Wolters U, Keller HW, Schlesinger A, Pichlmaier H. [Preoperative intestinal lavage with a polyethyleneglycol-containing solution. A prospective randomized study in comparison with Ringer's lactate solution]. Zentralblatt fur Chirurgie. 1992;117:412-416. 144. Initial report from a Swedish multicentre study examining the role of preoperative irradiation in the treatment of patients with resectable rectal carcinoma. Swedish Rectal Cancer Trial. The British journal of surgery. 1993;80:1333-1336. 145. Bonzanini C, Ubiali P, Invernizzi R. [The use of piperacillin in the preoperative prophylaxis of colorectal surgery]. Minerva chirurgica. 1993;48:1437-1443. 146. Brivio F, Lissoni P, Barni S, et al. Effects of a preoperative course of interleukin-2 on surgical and immunobiological variables in patients with colorectal cancer: a phase 2 study. The European journal of surgery = Acta chirurgica. 1993;159:43-47. 147. Cosimelli M, Tedesco M, Giannarelli D, et al. The role of the administration time of prophylactic antibiotic therapy in colorectal cancer surgery: a review of 6,069 patients from 36 randomized clinical trials. Annali italiani di chirurgia. 1993;64:527-532. 148. Coucke PA, Cuttat JF, Mirimanoff RO. Adjuvant postoperative accelerated hyperfractionated radiotherapy in rectal cancer: a feasibility study. International journal of radiation oncology, biology, physics. 1993;27:885-889. 149. Falk PM, Beart RW, Jr., Wexner SD, et al. Laparoscopic colectomy: a critical appraisal. Diseases of the colon and rectum. 1993;36:28-34. 150. Frykholm GJ, Glimelius B, Pahlman L. Preoperative or postoperative irradiation in adenocarcinoma of the rectum: final treatment results of a randomized trial and an evaluation of late secondary effects. Diseases of the colon and rectum. 1993;36:564-572. 151. Heiss MM, Mempel W, Delanoff C, Mempel M, Jauch KW, Schildberg FW. [Clinical effects of blood transfusion-associated immune modulation on outcome of tumor surgery]. Infusionstherapie und Transfusionsmedizin. 1993;20 Suppl 2:25-29. 152. Heiss MM, Mempel W, Jauch KW, et al. Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgery. Lancet. 1993;342:1328-1333. 153. Huber PJ, Jr., Reiss G. Rectal tumors: treatment with a posterior approach. American journal of surgery. 1993;166:760-763. 154. Minsky BD, Cohen AM, Kemeny N, et al. The efficacy of preoperative 5-fluorouracil, high-dose leucovorin, and sequential radiation therapy for unresectable rectal cancer. Cancer. 1993;71:3486-3492. 155. Murakami K, Watanabe T, Tadokoro M, et al. [Radioimmunodetection of colorectal cancer, using anti-CEA monoclonal antibody CEA102: experience of 20 cases]. Nihon Geka Gakkai zasshi. 1993;94:119-127. 156. Petrelli NJ, Stulc JP, Rodriguez-Bigas M, Blumenson L. Nasogastric decompression following elective colorectal surgery: a prospective randomized study. The American surgeon. 1993;59:632-635. 157. Quattlebaum JK, Jr., Flanders HD, Usher CH, 3rd. Laparoscopically assisted colectomy. Surgical laparoscopy & endoscopy. 1993;3:81-87. 158. Sagar PM, Couse N, Kerin M, May J, MacFie J. Randomized trial of drainage of colorectal anastomosis. The British journal of surgery. 1993;80:769-771. 159. Schirrmacher V, Schlag P, Liebrich W, Patel BT, Stoeck M. Specific immunotherapy of colorectal carcinoma with Newcastle-disease virus-modified autologous tumor cells prepared from resected liver metastasis. Annals of the New York Academy of Sciences. 1993;690:364-366. 160. Takahashi T, Horie H, Kojima O, Itoh M. Preoperative combined treatment with radiation, intraluminal hyperthermia, and 5-fluorouracil suppositories for patients with rectal cancer. Surgery today. 1993;23:1043-1048. 161. Tate JJ, Kwok S, Dawson JW, Lau WY, Li AK. Prospective comparison of laparoscopic and conventional anterior resection. The British journal of surgery. 1993;80:1396-1398. 162. Wolmark N, Rockette H, Fisher B, et al. The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1993;11:1879-1887. 163. Adams WJ, Morris DL, Ross WB, Lubowski DZ, King DW, Peters L. Cimetidine preserves non-specific immune function after colonic resection for cancer. The Australian and New Zealand journal of surgery. 1994;64:847-852. 164. AhChong K, Yip AW, Lee FC, Chiu KM. Comparison of prophylactic ampicillin/sulbactam with gentamicin and metronidazole in elective colorectal surgery: a randomized clinical study. The Journal of hospital infection. 1994;27:149-154. 165. Allardice JT, Abulafi AM, Grahn MF, Williams NS. Adjuvant intraoperative photodynamic therapy for colorectal carcinoma: a clinical study. Surgical oncology. 1994;3:1-10. 166. Braga M, Costantini E, Di Francesco A, Gianotti L, Baccari P, Di Carlo V. Impact of thymopentin on the incidence and severity of postoperative infection: a randomized controlled trial. The British journal of surgery. 1994;81:205-208. 167. Briusov PG, Inoiatov IM, Perekhodov SN. [Prevention of incompetence of sigmoid-rectal anastomosis after frontal resection of rectum in the treatment of cancer]. Khirurgiia. 1994:29-32. 168. Chlebowski RT, Lillington L, Nystrom JS, Sayre J. Late mortality and levamisole adjuvant therapy in colorectal cancer. British journal of cancer. 1994;69:1094-1097. 169. Costantino GN, Mukalian GG. Laparoscopic reversal of Hartmann procedure. Journal of laparoendoscopic surgery. 1994;4:429-433. 170. Delalande JP, Hay JM, Fingerhut A, Kohlmann G, Paquet JC. Perineal wound management after abdominoperineal rectal excision for carcinoma with unsatisfactory hemostasis or gross septic contamination: primary closure vs. packing. A multicenter, controlled trial. French Association for Surgical Research. Diseases of the colon and rectum. 1994;37:890-896. 171. Diez M, Cerdan FJ, Pollan M, et al. Prognostic significance of preoperative serum CA 19.9 assay in patients with colorectal carcinoma. Anticancer research. 1994;14:2819-2825. 172. Eckardt VF, Stamm H, Kanzler G, Bernhard G. Improved survival after colorectal cancer in patients complying with a postoperative endoscopic surveillance program. Endoscopy. 1994;26:523-527. 173. Elia P, Lombardo G, Delpiano C, Granello M. [Prevention of immunodeficiency and postoperative infective complications in patients undergoing surgical resection for carcinoma of the colon-rectum. Clinical study on 50 cases, using thymus hormones and thymopentin in particular]. Minerva chirurgica. 1994;49:575-580. 174. Elizarova AL, Madzhuga AV, Somonova OV, Larionova VB, Gorobets ES, Anan'ev VS. [Prevention of hemostatic disorders at different stages of surgical treatment in patients with colonic cancer]. Anesteziologiia i reanimatologiia. 1994:39-42. 175. Goeters C, Mertes N, Kuhmann M, Lange V, Dietl KH, Lawin P. [Safety and tolerance of a new dipeptide-containing amino acid solution DP-Gln 20 versus a conventional amino acid solution Vamin 18EF in patients after elective colon surgery]. Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS. 1994;29:146-149. 176. Heiss MM, Mempel W, Delanoff C, et al. Blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1994;12:1859-1867. 177. Hermanek P, Jr., Wiebelt H, Riedl S, Staimmer D, Hermanek P. [Long-term results of surgical therapy of colon cancer. Results of the Colorectal Cancer Study Group]. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen. 1994;65:287-297. 178. Houbiers JG, Brand A, van de Watering LM, et al. Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer. Lancet. 1994;344:573-578. 179. Houry S, Amenabar J, Rezvani A, Huguier M. Should patients over 80 years old be operated on for colorectal or gastric cancer? Hepato-gastroenterology. 1994;41:521-525. 180. Kawashima A, Goldman SM, Fishman EK, et al. CT of intraabdominal desmoid tumors: is the tumor different in patients with Gardner's disease? AJR. American journal of roentgenology. 1994;162:339-342. 181. Leen E, Angerson WJ, Wotherspoon H, Moule B, Cooke TG, McArdle CS. Comparison of the Doppler perfusion index and intraoperative ultrasonography in diagnosing colorectal liver metastases. Evaluation with postoperative follow-up results. Annals of surgery. 1994;220:663-667. 182. Letschert JG, Lebesque JV, Aleman BM, et al. The volume effect in radiation-related late small bowel complications: results of a clinical study of the EORTC Radiotherapy Cooperative Group in patients treated for rectal carcinoma. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 1994;32:116-123. 183. Mentges B, Buess G, Raestrup H, Manncke K, Becker HD. TEM results of the Tuebingen group. Endoscopic surgery and allied technologies. 1994;2:247-250. 184. Minsky BD, Enker WE, Cohen AM, Lauwers G. Local excision and postoperative radiation therapy for rectal cancer. American journal of clinical oncology. 1994;17:411-416. 185. Mobarhan S, Shiau A, Grande A, et al. beta-Carotene supplementation results in an increased serum and colonic mucosal concentration of beta-carotene and a decrease in alpha-tocopherol concentration in patients with colonic neoplasia. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 1994;3:501-505. 186. Nordlinger B, Vaillant JC, Guiguet M, et al. Survival benefit of repeat liver resections for recurrent colorectal metastases: 143 cases. Association Francaise de Chirurgie. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1994;12:1491-1496. 187. Odariuk TS, Kapuller LL, Podmarenkova LF, Tsar'kov PV, Frolov SA. [Long-term results of formation of smooth muscle sphincter in the perineal colostomy area in patients after rectal extirpation]. Khirurgiia. 1994:23-26. 188. O'Riordain MG, Fearon KC, Ross JA, et al. Glutamine-supplemented total parenteral nutrition enhances T-lymphocyte response in surgical patients undergoing colorectal resection. Annals of surgery. 1994;220:212-221. 189. Pedersen IK, Burcharth F, Roikjaer O, Baden H. Resection of liver metastases from colorectal cancer. Indications and results. Diseases of the colon and rectum. 1994;37:1078-1082. 190. Riethmuller G, Schneider-Gadicke E, Schlimok G, et al. Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group. Lancet. 1994;343:1177-1183. 191. Rouffet F, Hay JM, Vacher B, et al. Curative resection for left colonic carcinoma: hemicolectomy vs. segmental colectomy. A prospective, controlled, multicenter trial. French Association for Surgical Research. Diseases of the colon and rectum. 1994;37:651-659. 192. Sause WT, Pajak TF, Noyes RD, et al. Evaluation of preoperative radiation therapy in operable colorectal cancer. Annals of surgery. 1994;220:668-675. 193. Seifart W. Technique and results using the glass-rectoscope for tumour resection. Endoscopic surgery and allied technologies. 1994;2:265-268. 194. Tacke J, Bolder U, Lohlein D. Improved cumulated nitrogen balance after administration of recombinant human growth hormone in patients undergoing gastrointestinal surgery. Infusionstherapie und Transfusionsmedizin. 1994;21:24-29. 195. Wang FA, Liao HY, Yan QH. [Scanning electron microscopy of intestinal mucosa after enteric preparation in patients with carcinoma of large bowel]. Zhonghua wai ke za zhi [Chinese journal of surgery]. 1994;32:51-52. 196. Weiber S, Graf W, Glimelius B, Jiborn H, Pahlman L, Zederfeldt B. Experimental colonic healing in relation to timing of 5-fluorouracil therapy. The British journal of surgery. 1994;81:1677-1680. 197. Single-stage treatment for malignant left-sided colonic obstruction: a prospective randomized clinical trial comparing subtotal colectomy with segmental resection following intraoperative irrigation. The SCOTIA Study Group. Subtotal Colectomy versus On-table Irrigation and Anastomosis. The British journal of surgery. 1995;82:1622-1627. 198. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators. Lancet. 1995;345:939-944. 199. Altomare DF, Lupo L, Pannarale OC, Di Corcia MG, Memeo V. Reduction of postoperative immunosuppression with ranitidine in patients with cancer of the stomach or large bowel. The European journal of surgery = Acta chirurgica. 1995;161:109-113. 200. Arcangeli G, Angelini F, Arcangeli G, et al. A pilot study of concomitant protracted venous infusion 5-fluorouracil and hyperfractionated radiotherapy in rectal tumors. American journal of clinical oncology. 1995;18:369-375. 201. Bardram L, Funch-Jensen P, Jensen P, Crawford ME, Kehlet H. Recovery after laparoscopic colonic surgery with epidural analgesia, and early oral nutrition and mobilisation. Lancet. 1995;345:763-764. 202. Bertsch DJ, Burak WE, Jr., Young DC, Arnold MW, Martin EW, Jr. Radioimmunoguided Surgery system improves survival for patients with recurrent colorectal cancer. Surgery. 1995;118:634-638; discussion 638-639. 203. Buchmann P, Christen D, Flury R, Luthy A, Bischofberger U. [Does laparoscopic colonic carcinoma surgery satisfy the radicality criteria of open surgery?]. Schweizerische medizinische Wochenschrift. 1995;125:1825-1829. 204. Cedermark B, Johansson H, Rutqvist LE, Wilking N. The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma. A prospective randomized trial. Stockholm Colorectal Cancer Study Group. Cancer. 1995;75:2269-2275. 205. Ceragioli T, Nervi M, Marrucci G, Marioni A, Giuliani L. [Colorectal carcinoma in the elderly. Assessment of prognostic factors]. Minerva chirurgica. 1995;50:185-189. 206. Chen FC, Mackay JR, Woods RJ, Collopy BT, Fink RJ, Guiney MJ. Early experience with postoperative adjuvant chemoradiation for rectal carcinoma: focus on morbidity. The Australian and New Zealand journal of surgery. 1995;65:732-736. 207. Coucke PA, Sartorelli B, Cuttat JF, Jeanneret W, Gillet M, Mirimanoff RO. The rationale to switch from postoperative hyperfractionated accelerated radiotherapy to preoperative hyperfractionated accelerated radiotherapy in rectal cancer. International journal of radiation oncology, biology, physics. 1995;32:181-188. 208. D'Agostino G, Scollo MA, Vallo B, Robecchi A. [Current role of abdomino-perineal amputation]. Minerva chirurgica. 1995;50:325-329. 209. Docherty JG, McGregor JR, Akyol AM, Murray GD, Galloway DJ. Comparison of manually constructed and stapled anastomoses in colorectal surgery. West of Scotland and Highland Anastomosis Study Group. Annals of surgery. 1995;221:176-184. 210. Punt CJ, Nagy A, Douillard JY, et al. Edrecolomab alone or in combination with fluorouracil and folinic acid in the adjuvant treatment of stage III colon cancer: a randomised study. Lancet. 2002;360:671-677. 211. Sheen AJ, Poston GJ, Sherlock DJ. Cryotherapeutic ablation of liver tumours. The British journal of surgery. 2002;89:1396-1401. 212. Staib L, Link KH, Henne-Bruns D. [Interferon-alpha in adjuvant treatment of colorectal carcinoma]. Kongressband / Deutsche Gesellschaft fur Chirurgie. Deutsche Gesellschaft fur Chirurgie. Kongress. 2002;119:142-145. 213. Sugiyama Y, Kato T, Nakazato H, et al. Retrospective study on thymidylate synthase as a predictor of outcome and sensitivity to adjuvant chemotherapy in patients with curatively resected colorectal cancer. Anti-cancer drugs. 2002;13:931-938. 214. Tepper JE, O'Connell M, Niedzwiecki D, et al. Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control--final report of intergroup 0114. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2002;20:1744-1750. 215. Uzcudun AE, Batlle JF, Velasco JC, et al. Efficacy of preoperative radiation therapy for resectable rectal adenocarcinoma when combined with oral tegafur-uracil modulated with leucovorin: results from a phase II study. Diseases of the colon and rectum. 2002;45:1349-1358. 216. Vuong T, Belliveau PJ, Michel RP, et al. Conformal preoperative endorectal brachytherapy treatment for locally advanced rectal cancer: early results of a phase I/II study. Diseases of the colon and rectum. 2002;45:1486-1493; discussion 1493-1485. 217. Wibe A, Moller B, Norstein J, et al. A national strategic change in treatment policy for rectal cancer--implementation of total mesorectal excision as routine treatment in Norway. A national audit. Diseases of the colon and rectum. 2002;45:857-866. 218. Results of a randomized trial with or without 5-FU-based preoperative chemotherapy followed by postoperative chemotherapy in resected colon and rectal carcinoma. Japanese journal of clinical oncology. 2003;33:288-296. 219. Arkenau HT, Bermann A, Rettig K, Strohmeyer G, Porschen R. 5-Fluorouracil plus leucovorin is an effective adjuvant chemotherapy in curatively resected stage III colon cancer: long-term follow-up results of the adjCCA-01 trial. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2003;14:395-399. 220. Cafiero F, Gipponi M, Lionetto R. Randomised clinical trial of adjuvant postoperative RT vs. sequential postoperative RT plus 5-FU and levamisole in patients with stage II-III resectable rectal cancer: a final report. Journal of surgical oncology. 2003;83:140-146. 221. Cazacu M, Oniu T, Lungoci C, et al. The influence of isorel on the advanced colorectal cancer. Cancer biotherapy & radiopharmaceuticals. 2003;18:27-34. 222. Di Costanzo F, Sobrero A, Gasperoni S, et al. Adjuvant chemotherapy in the treatment of colon cancer: randomized multicenter trial of the Italian National Intergroup of Adjuvant Chemotherapy in Colon Cancer (INTACC). Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2003;14:1365-1372. 223. Feliciotti F, Guerrieri M, Paganini AM, et al. Long-term results of laparoscopic versus open resections for rectal cancer for 124 unselected patients. Surgical endoscopy. 2003;17:1530-1535. 224. Gerard JP, Chapet O, Nemoz C, et al. Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: the Lyon R0-04 phase II trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2003;21:1119-1124. 225. Isomoto H, Tomita M, Sugimachi K, et al. Pre- and post-operative adjuvant chemotherapy in colorectal cancer. International journal of oncology. 2003;23:1103-1108. 226. Kim DJ, Kim TI, Suh JH, et al. Oral tegafur-uracil plus folinic acid versus intravenous 5-fluorouracil plus folinic acid as adjuvant chemotherapy of colon cancer. Yonsei medical journal. 2003;44:665-675. 227. Koda K, Miyazaki M, Sarashina H, et al. A randomized controlled trial of postoperative adjuvant immunochemotherapy for colorectal cancer with oral medicines. International journal of oncology. 2003;23:165-172. 228. Kuechler A, Dreidax M, Pigorsch SU, et al. Residual chromosomal damage after radiochemotherapy with and without amifostine detected by 24-color FISH. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]. 2003;179:493-498. 229. Lorenz M, Staib-Sebler E, Gog C, et al. Prospective pilot study of neoadjuvant chemotherapy with 5-fluorouracil, folinic acid and oxaliplatin in resectable liver metastases of colorectal cancer. Analysis of 42 neoadjuvant chemotherapies. Zentralblatt fur Chirurgie. 2003;128:87-94. 230. Malinovskii NN, Severtsev AN, Smirnova NB. [Cytoreductive surgery of liver metastasis from colorectal cancer: principles of intra-arterial regional chemotherapy]. Khirurgiia. 2003:14-21. 231. Meyerhardt JA, Catalano PJ, Haller DG, et al. Impact of diabetes mellitus on outcomes in patients with colon cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2003;21:433-440. 232. Pilati P, Mocellin S, Rossi CR, et al. Cytoreductive surgery combined with hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis arising from colon adenocarcinoma. Annals of surgical oncology. 2003;10:508-513. 233. Sakamoto J, Hamashima H, Suzuki H, et al. Thymidylate synthase expression as a predictor of the prognosis of curatively resected colon carcinoma in patients registered in an adjuvant immunochemotherapy clinical trial. Oncology reports. 2003;10:1081-1090. 234. Sauer R, Fietkau R, Wittekind C, et al. Adjuvant vs. neoadjuvant radiochemotherapy for locally advanced rectal cancer: the German trial CAO/ARO/AIO-94. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland. 2003;5:406-415. 235. Scaife CL, Curley SA, Izzo F, et al. Feasibility of adjuvant hepatic arterial infusion of chemotherapy after radiofrequency ablation with or without resection in patients with hepatic metastases from colorectal cancer. Annals of surgical oncology. 2003;10:348-354. 236. Scheithauer W, McKendrick J, Begbie S, et al. Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2003;14:1735-1743. 237. Tepper JE, O'Connell M, Hollis D, Niedzwiecki D, Cooke E, Mayer RJ. Analysis of surgical salvage after failure of primary therapy in rectal cancer: results from Intergroup Study 0114. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2003;21:3623-3628. 238. Voelter V, Stupp R, Matter M, et al. Preoperative hyperfractionated accelerated radiotherapy (HART) and concomitant CPT-11 in locally advanced rectal carcinoma: a phase I study. International journal of radiation oncology, biology, physics. 2003;56:1288-1294. 239. Zelek L, Bugat R, Cherqui D, et al. Multimodal therapy with intravenous biweekly leucovorin, 5-fluorouracil and irinotecan combined with hepatic arterial infusion pirarubicin in non-resectable hepatic metastases from colorectal cancer (a European Association for Research in Oncology trial). Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2003;14:1537-1542. 240. Zhuchenko AP, Kalganov ID, Filon AF. [Cytoreductive surgery with intraperitoneal chemotherapy in patients with colon cancer and peritoneal carcinomatosis]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] / Ministerstvo meditsinskoi i mikrobiologicheskoi promyshlennosti SSSR. 2003;48:31-35. 241. Amthauer H, Denecke T, Rau B, et al. Response prediction by FDG-PET after neoadjuvant radiochemotherapy and combined regional hyperthermia of rectal cancer: correlation with endorectal ultrasound and histopathology. European journal of nuclear medicine and molecular imaging. 2004;31:811-819. 242. Bathe OF, Dowden S, Sutherland F, et al. Phase II study of neoadjuvant 5-FU + leucovorin + CPT-11 in patients with resectable liver metastases from colorectal adenocarcinoma. BMC cancer. 2004;4:32. 243. Bosset JF, Calais G, Daban A, et al. Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: assessment of acute toxicity and treatment compliance. Report of the 22921 randomised trial conducted by the EORTC Radiotherapy Group. European journal of cancer (Oxford, England : 1990). 2004;40:219-224. 244. Burmeister BH, Schache D, Burmeister EA, et al. Synchronous postoperative adjuvant chemoradiation therapy for locally advanced carcinoma of the rectum. International journal of colorectal disease. 2004;19:55-59. 245. Charara M, Edmonston TB, Burkholder S, et al. Microsatellite status and cell cycle associated markers in rectal cancer patients undergoing a combined regimen of 5-FU and CPT-11 chemotherapy and radiotherapy. Anticancer research. 2004;24:3161-3167. 246. Chau I, Allen MJ, Cunningham D, et al. The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2004;22:1420-1429. 247. Cheng J, Hong D, Zhu G, Swanstrom LL, Hansen PD. Laparoscopic placement of hepatic artery infusion pumps: technical considerations and early results. Annals of surgical oncology. 2004;11:589-597. 248. Elias D, Delperro JR, Sideris L, et al. Treatment of peritoneal carcinomatosis from colorectal cancer: impact of complete cytoreductive surgery and difficulties in conducting randomized trials. Annals of surgical oncology. 2004;11:518-521. 249. Fernandez-Martos C, Aparicio J, Bosch C, et al. Preoperative uracil, tegafur, and concomitant radiotherapy in operable rectal cancer: a phase II multicenter study with 3 years' follow-Up. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2004;22:3016-3022. 250. Glehen O, Kwiatkowski F, Sugarbaker PH, et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2004;22:3284-3292. 251. Inoue Y, Shirane M, Miki C, et al. Gene expression profiles of colorectal carcinoma in response to neo-adjuvant chemotherapy. International journal of oncology. 2004;25:1641-1649. 252. Ito K, Okushiba S, Morikawa T, Kondo S, Katoh H. [Appropriate duration of postoperative oral adjuvant chemotherapy with HCFU for colorectal cancer]. Gan to kagaku ryoho. Cancer & chemotherapy. 2004;31:55-59. 253. Ji ZL, Peng SY, Yuan AJ, Li PJ, Zhang W, Yu Y. Hepatic resection for metastasis from colorectal cancer. Techniques in coloproctology. 2004;8 Suppl 1:s47-49. 254. Martenson JA, Jr., Willett CG, Sargent DJ, et al. Phase III study of adjuvant chemotherapy and radiation therapy compared with chemotherapy alone in the surgical adjuvant treatment of colon cancer: results of intergroup protocol 0130. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2004;22:3277-3283. 255. Masi G, Allegrini G, Cupini S, et al. First-line treatment of metastatic colorectal cancer with irinotecan, oxaliplatin and 5-fluorouracil/leucovorin (FOLFOXIRI): results of a phase II study with a simplified biweekly schedule. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2004;15:1766-1772. 256. Chan AK, Wong A, Jenken D, Heine J, Buie D, Johnson D. Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy. International journal of radiation oncology, biology, physics. 2005;61:665-677. 257. Chau I, Norman AR, Cunningham D, et al. A randomised comparison between 6 months of bolus fluorouracil/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant treatment in colorectal cancer. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2005;16:549-557. 258. De Placido S, Lopez M, Carlomagno C, et al. Modulation of 5-fluorouracil as adjuvant systemic chemotherapy in colorectal cancer: the IGCS-COL multicentre, randomised, phase III study. British journal of cancer. 2005;93:896-904. 259. Delaunoit T, Alberts SR, Sargent DJ, et al. Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2005;16:425-429. 260. Elias D, Baton O, Sideris L, et al. Hepatectomy plus intraoperative radiofrequency ablation and chemotherapy to treat technically unresectable multiple colorectal liver metastases. Journal of surgical oncology. 2005;90:36-42. 261. Farkas E. [Fermented wheat germ extract in the supportive therapy of colorectal cancer]. Orvosi hetilap. 2005;146:1925-1931. 262. Fischer F, Mirow L, Gondeck C, Schwandner O, Bruch HP, Farke S. [Influence of adjuvant radio-chemotherapy for rectal cancer on quality of life]. Zeitschrift fur Gastroenterologie. 2005;43:1213-1218. 263. Giralt J, de las Heras M, Cerezo L, et al. The expression of epidermal growth factor receptor results in a worse prognosis for patients with rectal cancer treated with preoperative radiotherapy: a multicenter, retrospective analysis. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2005;74:101-108. 264. Kawai K, Watabe S, Matsuda M, Sakamoto K, Kamano T. Correlation between expression of orotate phosphoribosyl transferase and 5-fluorouracil sensitivity, as measured by apoptosis index in colorectal cancer tissue. International journal of gastrointestinal cancer. 2005;35:197-203. 265. Kusunoki M, Ikeuchi H, Yanagi H, et al. Bioresorbable hyaluronate-carboxymethylcellulose membrane (Seprafilm) in surgery for rectal carcinoma: a prospective randomized clinical trial. Surgery today. 2005;35:940-945. 266. Luo KY, Shao QH, Yang GK, et al. [125I seed implantation in sphincter preservation for treatment of low rectal cancer]. Zhonghua yi xue za zhi. 2005;85:1355-1357. 267. Lupattelli M, Maranzano E, Bellavita R, et al. Raltitrexed and radiotherapy as adjuvant treatment for stage II-III rectal cancer: a feasibility study. Tumori. 2005;91:498-504. 268. Niloofar A, Mosalaei A, Shapour O, Mohammadianpanah M. Role of external irradiation in high-risk resected colon cancer. Indian journal of cancer. 2005;42:133-137. 269. Nordlinger B, Rougier P, Arnaud JP, et al. Adjuvant regional chemotherapy and systemic chemotherapy versus systemic chemotherapy alone in patients with stage II-III colorectal cancer: a multicentre randomised controlled phase III trial. The lancet oncology. 2005;6:459-468. 270. Rengan R, Paty P, Wong WD, et al. Distal cT2N0 rectal cancer: is there an alternative to abdominoperineal resection? Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005;23:4905-4912. 271. Sadahiro S, Mitomi T, Noto T, et al. [Multicenter comparative study of the recurrence-inhibitory effect of oral fluoropyrimidine drugs in patients with colorectal cancer following curative resection]. Gan to kagaku ryoho. Cancer & chemotherapy. 2005;32:997-1005. 272. Taieb J, Artru P, Paye F, et al. Intensive systemic chemotherapy combined with surgery for metastatic colorectal cancer: results of a phase II study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005;23:502-509. 273. Takahashi Y, Mai M, Nakazato H. Preoperative CEA and PPD values as prognostic factors for immunochemotherapy using PSK and 5-FU. Anticancer research. 2005;25:1377-1384. 274. Turrini O, Guiramand J, Moutardier V, et al. [Major hepatectomy for metastasis of colorectal cancer improves survival in the elderly]. Annales de chirurgie. 2005;130:562-565. 275. Akasu T, Moriya Y, Ohashi Y, Yoshida S, Shirao K, Kodaira S. Adjuvant chemotherapy with uracil-tegafur for pathological stage III rectal cancer after mesorectal excision with selective lateral pelvic lymphadenectomy: a multicenter randomized controlled trial. Japanese journal of clinical oncology. 2006;36:237-244. 276. Benoist S, Brouquet A, Penna C, et al. Complete response of colorectal liver metastases after chemotherapy: does it mean cure? Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006;24:3939-3945. 277. Bosset JF, Collette L, Calais G, et al. Chemotherapy with preoperative radiotherapy in rectal cancer. The New England journal of medicine. 2006;355:1114-1123. 278. Elias D, Raynard B, Farkhondeh F, et al. Peritoneal carcinomatosis of colorectal origin. Gastroenterologie clinique et biologique. 2006;30:1200-1204. 279. Gan JL, Guo Y, Tang ZJ, Gao F, Tang WZ, Liu XJ. [Influence and significance of preoperative intraarterial infusion chemotherapy combined with radiotherapy on survivin, p53 and Bax expression in low rectal carcinoma]. Ai zheng = Aizheng = Chinese journal of cancer. 2006;25:1423-1427. 280. Hildebrandt B, Rau B, Loffel J, et al. Adjuvant chemotherapy with folinic acid and 5-fluorouracil in patients with locally advanced rectal cancer previously treated by preoperative radiochemotherapy and curative tumor resection. International journal of colorectal disease. 2006;21:582-589. 281. Klenova A, Parvanova V, Georgiev R, Gesheva N. Preoperative radiotherapy in rectal cancer: treatment results of three different dose regimens. Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 2006;11:161-166. 282. Krempien R, Roeder F, Oertel S, et al. Long-term results of intraoperative presacral electron boost radiotherapy (IOERT) in combination with total mesorectal excision (TME) and chemoradiation in patients with locally advanced rectal cancer. International journal of radiation oncology, biology, physics. 2006;66:1143-1151. 283. Luo L, Yang YF, Li PH. [Cohort study on fuzheng capsule and quxie capsule in reducing relapse and metastasis of cancer in patients with stage II and III colorectal carcinoma after operation]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine / Zhongguo Zhong xi yi jie he xue hui, Zhongguo Zhong yi yan jiu yuan zhu ban. 2006;26:677-680. 284. Martin RC, 2nd, Scoggins CR, McMasters KM. A phase II study of radiofrequency ablation of unresectable metastatic colorectal cancer with hepatic arterial infusion pump chemotherapy. Journal of surgical oncology. 2006;93:387-393. 285. Masi G, Cupini S, Marcucci L, et al. Treatment with 5-fluorouracil/folinic acid, oxaliplatin, and irinotecan enables surgical resection of metastases in patients with initially unresectable metastatic colorectal cancer. Annals of surgical oncology. 2006;13:58-65. 286. Movsas B, Diratzouian H, Hanlon A, et al. Phase II trial of preoperative chemoradiation with a hyperfractionated radiation boost in locally advanced rectal cancer. American journal of clinical oncology. 2006;29:435-441. 287. O'Connell MJ, Sargent DJ, Windschitl HE, et al. Randomized clinical trial of high-dose levamisole combined with 5-fluorouracil and leucovorin as surgical adjuvant therapy for high-risk colon cancer. Clinical colorectal cancer. 2006;6:133-139. 288. Portier G, Elias D, Bouche O, et al. Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006;24:4976-4982. 289. Pucciarelli S, Urso E, DeSalvo GL, et al. 5-fluorouracil and weekly oxaliplatin combined with radiotherapy for locally advanced rectal cancer: surgical complications and long-term results. Archives of medical research. 2006;37:860-865. 290. Sadahiro S, Suzuki T, Maeda Y, Makuuchi H, Murayama C. [Feasibility of weekday-on/weekend-off oral UFT/Leucovorin schedule as postoperative adjuvant chemotherapy for colorectal cancer]. Gan to kagaku ryoho. Cancer & chemotherapy. 2006;33:333-336. 291. Smalley SR, Benedetti JK, Williamson SK, et al. Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006;24:3542-3547. 292. Suwinski R, Wydmanski J, Pawelczyk I, Starzewski J. A pilot study of accelerated preoperative hyperfractionated pelvic irradiation with or without low-dose preoperative prophylactic liver irradiation in patients with locally advanced rectal cancer. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2006;80:27-32. 293. Taher AN, El-Baradie MM, Nasr AM, et al. Locally advanced rectal carcinoma: preoperative radiotherapy versus postoperative chemoradiation, 10-year follow-up results of a randomized clinical study. Journal of the Egyptian National Cancer Institute. 2006;18:233-243. 294. Urso E, Serpentini S, Pucciarelli S, et al. Complications, functional outcome and quality of life after intensive preoperative chemoradiotherapy for rectal cancer. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2006;32:1201-1208. 295. Valentini V, Morganti AG, Gambacorta MA, et al. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. International journal of radiation oncology, biology, physics. 2006;64:1129-1139. 296. Watanabe M, Kodaira S, Takahashi T, et al. Randomized trial of the efficacy of adjuvant chemotherapy for colon cancer with combination therapy incorporating the oral pyrimidine 1-hexylcarbamoyl-5-fluorouracil. Langenbeck's archives of surgery / Deutsche Gesellschaft fur Chirurgie. 2006;391:330-337. 297. Xu JM, Zhong YS, Niu WX, et al. [Preoperative hepatic and regional arterial infusion chemotherapy in the prevention of liver metastasis after colorectal cancer surgery]. Zhonghua yi xue za zhi. 2006;86:88-92. 298. Abitabile P, Hartl U, Lange J, Maurer CA. Radiofrequency ablation permits an effective treatment for colorectal liver metastasis. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2007;33:67-71. 299. Allen SD, Padhani AR, Dzik-Jurasz AS, Glynne-Jones R. Rectal carcinoma: MRI with histologic correlation before and after chemoradiation therapy. AJR. American journal of roentgenology. 2007;188:442-451. 300. Lanuke K, Mack LA, Temple WJ. Phase II study of regional treatment for peritoneal carcinomatosis. American journal of surgery. 2009;197:614-618; discussion 618. 301. Lin CP, Chi P. [Clinical study of postoperative intraperitoneal chemotherapy combined with systemic chemotherapy for serosa-involved colorectal cancer]. Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery. 2009;12:257-260. 302. Matsuoka H, Masaki T, Takayama M, et al. Impact of intra-operative radiotherapy on evacuatory function following ultra-low anterior resection. A preliminary result of prospective randomized trial. Hepato-gastroenterology. 2009;56:1656-1660. 303. Nguyen KT, Laurent A, Dagher I, et al. Minimally invasive liver resection for metastatic colorectal cancer: a multi-institutional, international report of safety, feasibility, and early outcomes. Annals of surgery. 2009;250:842-848. 304. Parc Y, Zutshi M, Zalinski S, Ruppert R, Furst A, Fazio VW. Preoperative radiotherapy is associated with worse functional results after coloanal anastomosis for rectal cancer. Diseases of the colon and rectum. 2009;52:2004-2014. 305. Roh MS, Colangelo LH, O'Connell MJ, et al. Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009;27:5124-5130. 306. Siegel R, Burock S, Wernecke KD, et al. Preoperative short-course radiotherapy versus combined radiochemotherapy in locally advanced rectal cancer: a multi-centre prospectively randomised study of the Berlin Cancer Society. BMC cancer. 2009;9:50. 307. Bellmunt J, Albanell J, Paz-Ares L, et al. Pretreatment prognostic factors for survival in patients with advanced urothelial tumors treated in a phase I/II trial with paclitaxel, cisplatin, and gemcitabine. Cancer. 2002;95:751-757. 308. Bellmunt J, Choueiri TK, Fougeray R, et al. Prognostic factors in patients with advanced transitional cell carcinoma of the urothelial tract experiencing treatment failure with platinum-containing regimens. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2010;28:1850-1855. 309. Benavides M, Pericay C, Valladares-Ayerbes M, et al. Oxaliplatin in combination with infusional 5-fluorouracil as first-line chemotherapy for elderly patients with metastatic colorectal cancer: a phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumors. Clinical colorectal cancer. 2012;11:200-206. 310. Ben-Baruch N, Denicoff AM, Goldspiel BR, O'Shaughnessy JA, Cowan KH. Phase II study of fazarabine (NSC 281272) in patients with metastatic colon cancer. Investigational new drugs. 1993;11:71-74. 311. Bender H, Bangard N, Metten N, et al. Possible role of FDG-PET in the early prediction of therapy outcome in liver metastases of colorectal cancer. Hybridoma. 1999;18:87-91. 312. Benevento A, Dominioni L, Carcano G, Dionigi R. Intraoperative localization of gut endocrine tumors with radiolabeled somatostatin analogs and a gamma-detecting probe. Seminars in surgical oncology. 1998;15:239-244. 313. Brown J, Perilongo G, Shafford E, et al. Pretreatment prognostic factors for children with hepatoblastoma-- results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1. European journal of cancer (Oxford, England : 1990). 2000;36:1418-1425. 314. Homayounfar K, Bleckmann A, Conradi LC, et al. Bilobar spreading of colorectal liver metastases does not significantly affect survival after R0 resection in the era of interdisciplinary multimodal treatment. International journal of colorectal disease. 2012;27:1359-1367. 315. Homayounfar K, Liersch T, Schuetze G, et al. Two-stage hepatectomy (R0) with portal vein ligation--towards curing patients with extended bilobular colorectal liver metastases. International journal of colorectal disease. 2009;24:409-418. 316. Sadahiro S, Ohki S, Yamaguchi S, et al. [Optimal dosage of UFT in a weekday-on/weekend-off schedule as a postoperative adjuvant chemotherapy for colorectal cancer]. Gan to kagaku ryoho. Cancer & chemotherapy. 2000;27:2223-2230. 317. Sadahiro S, Ohki S, Yamaguchi S, et al. Feasibility of a novel weekday-on/weekend-off oral UFT schedule as postoperative adjuvant chemotherapy for colorectal cancer. UFT Compliance Study Group, Kanagawa, Japan. Cancer chemotherapy and pharmacology. 2000;46:180-184. 318. Sauer R, Fietkau R, Wittekind C, et al. Adjuvant versus neoadjuvant radiochemotherapy for locally advanced rectal cancer. A progress report of a phase-III randomized trial (protocol CAO/ARO/AIO-94). Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]. 2001;177:173-181. 319. Sauer R, Liersch T, Merkel S, et al. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2012;30:1926-1933. 320. Scheithauer W, Kornek G, Rosen H, et al. Combined intraperitoneal plus intravenous chemotherapy after curative resection for colonic adenocarcinoma. European journal of cancer (Oxford, England : 1990). 1995;31A:1981-1986. 321. Scheithauer W, Kornek GV, Marczell A, et al. Combined intravenous and intraperitoneal chemotherapy with fluorouracil + leucovorin vs fluorouracil + levamisole for adjuvant therapy of resected colon carcinoma. British journal of cancer. 1998;77:1349-1354. 322. Schmitt G, Pape H, Neu A, Zamboglou N. [Value of radiotherapy in the interdisciplinary therapeutic treatment concept of rectal cancer]. Der Radiologe. 1986;26:381-384. 323. Schrag D, Weiser MR, Goodman KA, et al. Neoadjuvant chemotherapy without routine use of radiation therapy for patients with locally advanced rectal cancer: a pilot trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2014;32:513-518. 324. Schultheis KH, Gebhardt C, Schwemmle K, Richter EI, Schumacher F. [Chemoembolization of colorectal liver metastases]. Zentralblatt fur Chirurgie. 1990;115:933-947. 325. Sertoli MR, Guarneri D, Rubagotti A, Porcile G, Nobile MT, Rosso R. Adjuvant immunochemotherapy in colorectal cancer Dukes C. Oncology. 1987;44:78-81. 326. Shen P, Thai K, Stewart JH, et al. Peritoneal surface disease from colorectal cancer: comparison with the hepatic metastases surgical paradigm in optimally resected patients. Annals of surgical oncology. 2008;15:3422-3432. 327. Shimada H, Ozaki M, Ariga T, et al. [Experience in intra-hepatic-arterial chemotherapy and hepatic resection for metastatic colorectal cancer]. Gan to kagaku ryoho. Cancer & chemotherapy. 1995;22:1570-1572. 328. Sinicrope FA, Mahoney MR, Smyrk TC, et al. Prognostic impact of deficient DNA mismatch repair in patients with stage III colon cancer from a randomized trial of FOLFOX-based adjuvant chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2013;31:3664-3672. 329. Smeenk RM, Verwaal VJ, Zoetmulder FA. Learning curve of combined modality treatment in peritoneal surface disease. The British journal of surgery. 2007;94:1408-1414. 330. Smith R, Wickerham DL, Wieand HS, Colangelo L, Mamounas EP. UFT plus calcium folinate vs 5-FU plus calcium folinate in colon cancer. Oncology (Williston Park, N.Y.). 1999;13:44-47. 331. Smith RE, Colangelo L, Wieand HS, Begovic M, Wolmark N. Randomized trial of adjuvant therapy in colon carcinoma: 10-year results of NSABP protocol C-01. Journal of the National Cancer Institute. 2004;96:1128-1132. 332. Smith RE, Lembersky BC, Wieand HS, Colangelo L, Mamounas EP. UFT/leucovorin vs 5-FU/leucovorin in colon cancer. Oncology (Williston Park, N.Y.). 2000;14:24-27. 333. Sparso BH, Von der Maase H, Kristensen D, et al. Complications following postoperative combined radiation and chemotherapy in adenocarcinoma of the rectum and rectosigmoid. A randomized trial that failed. Cancer. 1984;54:2363-2366. 334. Staib L, Link KH, Beger HG. Toxicity and effects of adjuvant therapy in colon cancer: results of the German prospective, controlled randomized multicenter trial FOGT-1. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2001;5:275-281. 335. Stein A, Glockzin G, Wienke A, et al. Treatment with bevacizumab and FOLFOXIRI in patients with advanced colorectal cancer: presentation of two novel trials (CHARTA and PERIMAX) and review of the literature. BMC cancer. 2012;12:356. 336. Steinberg SM, Barwick KW, Stablein DM. Importance of tumor pathology and morphology in patients with surgically resected colon cancer. Findings from the Gastrointestinal Tumor Study Group. Cancer. 1986;58:1340-1345. 337. Strocchi E, Iaffaioli RV, Facchini G, et al. Stop-flow technique for loco-regional delivery of high dose chemotherapy in the treatment of advanced pelvic cancers. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2004;30:663-670. 338. Sugimachi K, Maehara Y, Ogawa M, Kakegawa T, Tomita M, Akiyoshi T. Postoperative chemotherapy for colorectal cancer by combining 5-fluorouracil infusion and 1-hexylcarbamoyl-5-fluorouracil administration after curative resection. Cancer. 1996;77:36-43. 339. Sun N, Cai Z, Zhang C. [Early postoperative intraperitoneal perfusion chemotherapy for advanced colorectal cancer]. Zhonghua zhong liu za zhi [Chinese journal of oncology]. 1998;20:222-224. 340. Suzuka I, Izumi S, Onoda Y, et al. [Usefulness of pharmacokinetic modulating chemotherapy (PMC) for the postoperative adjuvant therapy of colorectal carcinoma: a preliminary report]. Gan to kagaku ryoho. Cancer & chemotherapy. 1999;26:2183-2188. 341. Szynglarewicz B, Matkowski R, Halon A, et al. Association between histological type of tumour growth and patient survival in t2-t3 lymph node-negative rectal cancer treated with sphincter-preserving total mesorectal excision. Pathology oncology research : POR. 2010;16:201-206. 342. Takahashi T, Kato T, Kodaira S, et al. Prognostic factors of colorectal cancer. Results of multivariate analysis of curative resection cases with or without adjuvant chemotherapy. American journal of clinical oncology. 1996;19:408-415. 343. Takashima S, Kinami Y, Miyazaki I. [Clinical effect of postoperative adjuvant immunochemotherapy with the FT-207 suppository and PSK in colorectal cancer patients. Colorectal Cancer Chemotherapy Group in Hokuriku]. Gan to kagaku ryoho. Cancer & chemotherapy. 1988;15:2229-2236. 344. Takashima S, Kosaka T, Ueno K, Fujita H, Miyazaki I. [Evaluation of preoperative administration of N1-(2-tetrahydrofuryl)-5-fluorouracil (FT-207) suppository in surgical adjuvant chemotherapy for large bowel cancer]. Gan to kagaku ryoho. Cancer & chemotherapy. 1984;11:2362-2371. 345. Takashima S, Tomita F, Saito H, et al. [Clinical effect of postoperative adjuvant chemotherapy for advanced colorectal cancer--comparisons of between tegafur (FT) and UFT]. Gan to kagaku ryoho. Cancer & chemotherapy. 1991;18:2315-2324. 346. Takebayashi K, Mekata E, Sonoda H, et al. Differences in chemosensitivity between primary and metastatic tumors in colorectal cancer. PloS one. 2013;8:e73215. 347. Takenoue T, Nagawa H, Matsuda K, et al. Relation between thymidylate synthase expression and survival in colon carcinoma, and determination of appropriate application of 5-fluorouracil by immunohistochemical method. Annals of surgical oncology. 2000;7:193-198. 348. Takii Y, Shimada Y, Moriya Y, et al. A randomized controlled trial of the conventional technique versus the no-touch isolation technique for primary tumor resection in patients with colorectal cancer: Japan Clinical Oncology Group Study JCOG1006. Japanese journal of clinical oncology. 2014;44:97-100. 349. Tang YQ, Tan ZM, Wang JK, et al. [Preoperative intra-arterial chemotherapy for progressive lower rectal cancer]. Nan fang yi ke da xue xue bao = Journal of Southern Medical University. 2008;28:1247-1248. 350. Taucher S, Steger GG, Jakesz R, et al. The potential risk of neoadjuvant chemotherapy in breast cancer patients--results from a prospective randomized trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-07). Breast cancer research and treatment. 2008;112:309-316. 351. Tentes AA, Mirelis C, Karanikiotis C, Korakianitis O. Radical lymph node resection of the retroperitoneal area for left-sided colon cancer. Langenbeck's archives of surgery / Deutsche Gesellschaft fur Chirurgie. 2007;392:155-160. 352. Tepper JE, O'Connell MJ, Petroni GR, et al. Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: initial results of intergroup 0114. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1997;15:2030-2039. 353. Terabe K, Yamauchi M, Watanabe T, et al. [Prospective adjuvant chemotherapy, with mitomycin C plus long-term carmofur in colorectal cancer]. Gan no rinsho. Japan journal of cancer clinics. 1986;32:261-267. 354. Tevis SE, Kohlnhofer BM, Stringfield S, et al. Postoperative complications in patients with rectal cancer are associated with delays in chemotherapy that lead to worse disease-free and overall survival. Diseases of the colon and rectum. 2013;56:1339-1348. 355. Thomas PR, Lindblad AS. Adjuvant postoperative radiotherapy and chemotherapy in rectal carcinoma: a review of the Gastrointestinal Tumor Study Group experience. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 1988;13:245-252. 356. Thomas PR, Stablein DM, Kinzie JJ, et al. Perineal effects of postoperative treatment for adenocarcinoma of the rectum. International journal of radiation oncology, biology, physics. 1986;12:167-171. 357. Thomas PR, Stablein DM, Steinberg SM, Barkin JS, Nauta RJ. The effects of liver directed radiotherapy and chemotherapy on liver function tests and hematological parameters in patients with surgically resected colon cancer: findings from the Gastrointestinal Tumor Study Group. The American journal of gastroenterology. 1987;82:738-743. 358. Tominaga T, Sakabe T, Koyama Y, et al. Prognostic factors for patients with colon or rectal carcinoma treated with resection only. Five-year follow-up report. Cancer. 1996;78:403-408. 359. Tsavaris N, Gennatas K, Kosmas C, et al. Leucovorin and fluorouracil vs levamisole and fluorouracil as adjuvant chemotherapy in rectal cancer. Oncology reports. 2004;12:927-932. 360. Tsilimparis N, Bockelmann C, Raue W, et al. Quality of life in patients after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: is it worth the risk? Annals of surgical oncology. 2013;20:226-232. 361. Tu SL, Yuan JH, Deng GL, et al. [Study of prophylactic intra-iliac and hepatic arterial infusion chemotherapy against pelvic recurrence and liver metastasis after radical resection for rectal cancer]. Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery. 2007;10:149-152. 362. Uehara K, Hiramatsu K, Maeda A, et al. Neoadjuvant oxaliplatin and capecitabine and bevacizumab without radiotherapy for poor-risk rectal cancer: N-SOG 03 Phase II trial. Japanese journal of clinical oncology. 2013;43:964-971. 363. Uehara K, Maeda A, Sakamoto E, et al. Phase II trial of adjuvant chemotherapy with S-1 for colorectal liver metastasis. Annals of surgical oncology. 2013;20:475-481. 364. Uematsu T, Nakashima M, Fujii M, et al. Measurement of 5-fluorouracil in scalp hair: a possible index of patient compliance with oral adjuvant chemotherapy. European journal of clinical pharmacology. 1996;50:109-113. 365. Valencia J, Esco R, Polo S, Bascon N, Escudero P, Alonso V. Postoperative radiochemotherapy in rectal cancer comparison of two combination schemes: alternating versus concomitant. Tumori. 2004;90:216-224. 366. Watanabe M, Nishida O, Kunii Y, et al. Randomized controlled trial of the efficacy of adjuvant immunochemotherapy and adjuvant chemotherapy for colorectal cancer, using different combinations of the intracutaneous streptococcal preparation OK-432 and the oral pyrimidines 1-hexylcarbamoyl-5-fluorouracil and uracil/tegafur. International journal of clinical oncology. 2004;9:98-106. 367. Weber W, Maibach R, Laffer U, et al. Early hematological toxicity of adjuvant perioperative intraportal and intravenous chemotherapy with fluorouracil, mitomycin and heparin in colorectal cancer. Swiss Group for Clinical Cancer Research. Anticancer research. 1995;15:2197-2200. 368. Weber W, Metzger U, Laffer U, Egeli R. Hematological toxicity of adjuvant portal liver infusion with fluorouracil, mitomycin and heparin. Anticancer research. 1991;11:365-368. 369. Weiss RB, DeVita VT, Jr. The dilemma regarding postoperative chemotherapy in primary carcinoma of the colon. Surgery, gynecology & obstetrics. 1979;149:267-271. 370. Willett CG, Goldberg S, Shellito PC, et al. Does postoperative irradiation play a role in the adjuvant therapy of stage T4 colon cancer? The cancer journal from Scientific American. 1999;5:242-247. 371. Wolmark N, Fisher B, Rockette H, et al. Postoperative adjuvant chemotherapy or BCG for colon cancer: results from NSABP protocol C-01. Journal of the National Cancer Institute. 1988;80:30-36. 372. Wolmark N, Rockette H, Wickerham DL, et al. Adjuvant therapy of Dukes' A, B, and C adenocarcinoma of the colon with portal-vein fluorouracil hepatic infusion: preliminary results of National Surgical Adjuvant Breast and Bowel Project Protocol C-02. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1990;8:1466-1475. 373. Wolmark N, Wieand HS, Hyams DM, et al. Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02. Journal of the National Cancer Institute. 2000;92:388-396. 374. Wright JC. Update in cancer chemotherapy: gastrointestinal cancer--colorectal cancer, Part 2. Journal of the National Medical Association. 1986;78:395-408. 375. Wu JG, Huang WZ, Wu BY. [Effect of acupoint irradiation with Q-wave millimeter microwave on peripheral white blood cells in post-operational treatment with chemotherapy in stomach and colorectal cancer patients]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine / Zhongguo Zhong xi yi jie he xue hui, Zhongguo Zhong yi yan jiu yuan zhu ban. 1997;17:286-288. 376. Yamada Y, Takahari D, Matsumoto H, et al. Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial. The lancet oncology. 2013;14:1278-1286. 377. Yamaguchi A, Maeda A, Hachisuka K, et al. [Study of 5'-DFUR treatment as postoperative adjuvant chemotherapy for stomach and colorectal cancer. Tokai GATS Group (pilot study)]. Gan to kagaku ryoho. Cancer & chemotherapy. 1994;21:621-626. 378. Yang XJ, Li Y, al-shammaa Hassan AH, et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival in selected patients with peritoneal carcinomatosis from abdominal and pelvic malignancies: results of 21 cases. Annals of surgical oncology. 2009;16:345-351. 379. Yasutomi M, Takahashi T, Kodaira S, et al. [Prospective controlled study on the usefulness of Carmofur as a postoperative adjuvant chemotherapy for colorectal cancer]. Gan to kagaku ryoho. Cancer & chemotherapy. 1997;24:1953-1960. 380. Yau T, Watkins D, Cunningham D, Barbachano Y, Chau I, Chong G. Longitudinal assessment of quality of life in rectal cancer patients with or without stomas following primary resection. Diseases of the colon and rectum. 2009;52:669-677. 381. Yoon WS, Park W, Choi DH, et al. Which patients benefit from preoperative chemoradiotherapy for intermediate staged rectal cancer? Onkologie. 2011;34:36-41. 382. Yu TK, Bhosale PR, Crane CH, et al. Patterns of locoregional recurrence after surgery and radiotherapy or chemoradiation for rectal cancer. International journal of radiation oncology, biology, physics. 2008;71:1175-1180. 383. Yukawa N, Yamamoto Y, Akaike M, et al. [Modified FOLFIRI (l-LV, 5-fluorouracil and irinotecan) therapy for Japanese patients with metastatic colorectal cancer]. Gan to kagaku ryoho. Cancer & chemotherapy. 2010;37:1291-1295. 384. Zaniboni A, Labianca R, Marsoni S, et al. GIVIO-SITAC 01: A randomized trial of adjuvant 5-fluorouracil and folinic acid administered to patients with colon carcinoma--long term results and evaluation of the indicators of health-related quality of life. Gruppo Italiano Valutazione Interventi in Oncologia. Studio Italiano Terapia Adiuvante Colon. Cancer. 1998;82:2135-2144. 385. Velenik V, Oblak I, Anderluh F. Long-term results from a randomized phase II trial of neoadjuvant combined-modality therapy for locally advanced rectal cancer. Radiation oncology (London, England). 2010;5:88. 386. von der Maase H, Magnusson K, Sveinsson T. Combined irradiation and three-drug chemotherapy in inoperable colorectal carcinoma. Acta radiologica. Oncology. 1982;21:369-372. 387. Wagman R, Minsky BD, Cohen AM, Guillem JG, Paty PP. Sphincter preservation in rectal cancer with preoperative radiation therapy and coloanal anastomosis: long term follow-up. International journal of radiation oncology, biology, physics. 1998;42:51-57. 388. Wan DS. [Reevaluation of intraluminal fluorouracil chemotherapy as an adjuvant to radical resection of colorectal cancer--results of a randomized trial]. Zhonghua zhong liu za zhi [Chinese journal of oncology]. 1988;10:388-391. 389. Santini D, Vincenzi B, Addeo R, et al. Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance? Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2012;23:2313-2318. 390. Santini D, Vincenzi B, Massacesi C, et al. S-adenosylmethionine (AdoMet) supplementation for treatment of chemotherapy-induced liver injury. Anticancer research. 2003;23:5173-5179. 391. Santini D, Vincenzi B, Schiavon G, et al. Chronomodulated administration of oxaliplatin plus capecitabine (XELOX) as first line chemotherapy in advanced colorectal cancer patients: phase II study. Cancer chemotherapy and pharmacology. 2007;59:613-620. 392. Sanz-Altamira PM, Spence LD, Huberman MS, et al. Selective chemoembolization in the management of hepatic metastases in refractory colorectal carcinoma: a phase II trial. Diseases of the colon and rectum. 1997;40:770-775. 393. Saridaki Z, Androulakis N, Vardakis N, et al. A triplet combination with irinotecan (CPT-11), oxaliplatin (LOHP), continuous infusion 5-fluorouracil and leucovorin (FOLFOXIRI) plus cetuximab as first-line treatment in KRAS wt, metastatic colorectal cancer: a pilot phase II trial. British journal of cancer. 2012;107:1932-1937. 394. Sasaki Y, Shimizu H, Naka W, Takeshita E, Nishikawa T. Evaluation of the clinical usefulness of measuring urinary excretion of 5-S-cysteinyldopa in melanoma: ten years' experience of 50 patients. Acta dermato-venereologica. 1997;77:379-381. 395. Sato A, Kurihara M, Horikoshi N, et al. Phase II study of raltitrexed (Tomudex) in chemotherapy-pretreated patients with advanced colorectal cancer. Tomudex Cooperative Study Group. Anti-cancer drugs. 1999;10:741-748. 396. Sato KT, Omary RA, Takehana C, et al. The role of tumor vascularity in predicting survival after yttrium-90 radioembolization for liver metastases. Journal of vascular and interventional radiology : JVIR. 2009;20:1564-1569. 397. Sato M, Watanabe Y, Ueda S, et al. Microwave coagulation therapy for hepatocellular carcinoma. Gastroenterology. 1996;110:1507-1514. 398. Sato N, Sano M, Tabei T, et al. Combination docetaxel and trastuzumab treatment for patients with HER-2-overexpressing metastatic breast cancer: a multicenter, phase-II study. Breast cancer (Tokyo, Japan). 2006;13:166-171. 399. Sato T, Eschelman DJ, Gonsalves CF, et al. Immunoembolization of malignant liver tumors, including uveal melanoma, using granulocyte-macrophage colony-stimulating factor. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008;26:5436-5442. 400. Satoi S, Yamamoto H, Takai S, et al. Clinical impact of multidetector row computed tomography on patients with pancreatic cancer. Pancreas. 2007;34:175-179. 401. Saunders MP, Hogg M, Carrington B, et al. Phase I dose-escalation trial of irinotecan with continuous infusion 5-FU first line, in metastatic colorectal cancer. British journal of cancer. 2004;91:1447-1452. 402. Sautner T, Hofbauer F, Depisch D, Schiessel R, Jakesz R. Adjuvant intraperitoneal cisplatin chemotherapy does not improve long-term survival after surgery for advanced gastric cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1994;12:970-974. 403. Savelli G, Lucignani G, Seregni E, et al. Feasibility of somatostatin receptor scintigraphy in the detection of occult primary gastro-entero-pancreatic (GEP) neuroendocrine tumours. Nuclear medicine communications. 2004;25:445-449. 404. Sawaguchi S, Kaneko M, Uchino J, et al. Treatment of advanced neuroblastoma with emphasis on intensive induction chemotherapy. A report from the Study Group of Japan. Cancer. 1990;66:1879-1887. 405. Schaaf LJ, Hammond LA, Tipping SJ, et al. Phase 1 and pharmacokinetic study of intravenous irinotecan in refractory solid tumor patients with hepatic dysfunction. Clinical cancer research : an official journal of the American Association for Cancer Research. 2006;12:3782-3791. 406. Schafer HH, Vivaldi C, Holscher AH. [Local excision with transanal endoscopic microsurgery (TEM) after endoscopic R1/R2-polypectomy of pT1 "low-risk" carcinomas of the rectum]. Zeitschrift fur Gastroenterologie. 2006;44:647-650. 407. Scheer MG, Stollman TH, Vogel WV, Boerman OC, Oyen WJ, Ruers TJ. Increased metabolic activity of indolent liver metastases after resection of a primary colorectal tumor. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2008;49:887-891. 408. Schefter TE, Kavanagh BD, Timmerman RD, Cardenes HR, Baron A, Gaspar LE. A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases. International journal of radiation oncology, biology, physics. 2005;62:1371-1378. 409. Scheibenbogen C, Schmittel A, Keilholz U, et al. Phase 2 trial of vaccination with tyrosinase peptides and granulocyte-macrophage colony-stimulating factor in patients with metastatic melanoma. Journal of immunotherapy (Hagerstown, Md. : 1997). 2000;23:275-281. 410. Scheidhauer K, Muller S, Smolarz K, Brautigam P, Briele B. [Tumor scintigraphy using 123I-labeled estradiol in breast cancer--receptor scintigraphy]. Nuklearmedizin. Nuclear medicine. 1991;30:84-99. 411. Scheithauer W, Schull B, Ulrich-Pur H, et al. Biweekly high-dose gemcitabine alone or in combination with capecitabine in patients with metastatic pancreatic adenocarcinoma: a randomized phase II trial. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2003;14:97-104. 412. Schiavon G, Ruggiero A, Bekers DJ, et al. The effect of baseline morphology and its change during treatment on the accuracy of Response Evaluation Criteria in Solid Tumours in assessment of liver metastases. European journal of cancer (Oxford, England : 1990). 2014;50:972-980. 413. Schick F, Stern W, Forster J, Laniado M, Lutz O, Claussen CD. Magnetization transfer contrast of hepatic lesions in breath-hold gradient-echo images of different T1 weighting. Journal of magnetic resonance imaging : JMRI. 1997;7:280-285. 414. Schiepers C, Haustermans K, Geboes K, Filez L, Bormans G, Penninckx F. The effect of preoperative radiation therapy on glucose utilization and cell kinetics in patients with primary rectal carcinoma. Cancer. 1999;85:803-811. 415. Schiepers C, Penninckx F, De Vadder N, et al. Contribution of PET in the diagnosis of recurrent colorectal cancer: comparison with conventional imaging. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 1995;21:517-522. 416. Schilling H, Bornfeld N, Talies S, et al. [Endoresection of large uveal melanomas after pretreatment by single-dose stereotactic convergence irradiation with the leksell gamma knife--first experience on 46 cases]. Klinische Monatsblatter fur Augenheilkunde. 2006;223:513-520. 417. Schimanski CC, Mohler M, Schon M, et al. LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases: a randomized, placebo-controlled, multicenter, multinational, double-blinded phase II trial. BMC cancer. 2012;12:144. 418. Schindler CG, Armbrust T, Gunawan B, Langer C, Fuzesi L, Ramadori G. Gastrointestinal stromal tumor (GIST) -- single center experience of prolonged treatment with imatinib. Zeitschrift fur Gastroenterologie. 2005;43:267-273. 419. Schirrmeister H, Kuhn T, Guhlmann A, et al. Fluorine-18 2-deoxy-2-fluoro-D-glucose PET in the preoperative staging of breast cancer: comparison with the standard staging procedures. European journal of nuclear medicine. 2001;28:351-358. 420. Schlag P, Manasterski M, Gerneth T, et al. Active specific immunotherapy with Newcastle-disease-virus-modified autologous tumor cells following resection of liver metastases in colorectal cancer. First evaluation of clinical response of a phase II-trial. Cancer immunology, immunotherapy : CII. 1992;35:325-330. 421. Schlottmann K, Klebl F, Zorger N, Feuerbach S, Scholmerich J. Contrast-enhanced ultrasound allows for interventions of hepatic lesions which are invisible on convential B-mode. Zeitschrift fur Gastroenterologie. 2004;42:303-310. 422. Schmid P, Akrivakis K, Flath B, et al. Phase II trial of gemcitabine as prolonged infusion in metastatic breast cancer. Anti-cancer drugs. 1999;10:625-631. 423. Schmid P, Heilmann V, Schulz CO, et al. Gemcitabine as prolonged infusion and vinorelbine in anthracycline and/or taxane pretreated metastatic breast cancer: a phase II study. Journal of cancer research and clinical oncology. 2005;131:568-574. 424. Schmidt GP, Baur-Melnyk A, Herzog P, et al. High-resolution whole-body magnetic resonance image tumor staging with the use of parallel imaging versus dual-modality positron emission tomography-computed tomography: experience on a 32-channel system. Investigative radiology. 2005;40:743-753. 425. Schmidt JD, Gibbons RP, Johnson DE, Prout GR, Scott WW, Murphy GP. Chemotherapy of advanced prostatic cancer. Evaluation of response parameters. Urology. 1976;7:602-610. 426. Schmidt T, Koch M, Antolovic D, et al. Influence of two different resection techniques (conventional liver resection versus anterior approach) of liver metastases from colorectal cancer on hematogenous tumor cell dissemination - prospective randomized multicenter trial. BMC surgery. 2008;8:6. 427. Schmitz R, Krakamp B, Mennigen R, Barkun J, Klauke H. Value of in vivo tissue testing in predicting the clinical response to regional perfusion chemotherapy in colorectal cancer patients with liver metastases. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]. 1989;165:546-547. 428. Schmitz SA, Haberle JH, Balzer T, Shamsi K, Boese-Landgraf J, Wolf KJ. Detection of focal liver lesions: CT of the hepatobiliary system with gadoxetic acid disodium, or Gd-EOB-DTPA. Radiology. 1997;202:399-405. 429. Schmitz T, Appelman K, Kudejova P, et al. Determination of boron concentration in blood and tissue samples from patients with liver metastases of colorectal carcinoma using Prompt Gamma Ray Activation Analysis (PGAA). Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine. 2011;69:936-941. 430. Schmitz T, Blaickner M, Schutz C, et al. Dose calculation in biological samples in a mixed neutron-gamma field at the TRIGA reactor of the University of Mainz. Acta oncologica (Stockholm, Sweden). 2010;49:1165-1169. 431. Schnater JM, Aronson DC, Plaschkes J, et al. Surgical view of the treatment of patients with hepatoblastoma: results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study Group. Cancer. 2002;94:1111-1120. 432. Schneebaum S, Papo J, Graif M, Baratz M, Baron J, Skornik Y. Radioimmunoguided surgery benefits for recurrent colorectal cancer. Annals of surgical oncology. 1997;4:371-376. 433. Schneebaum S, Troitsa A, Avital S, et al. Identification of lymph node metastases in recurrent colorectal cancer. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer. 2000;157:281-292. 434. Schneider BJ, El-Rayes B, Muler JH, et al. Phase II trial of carboplatin, gemcitabine, and capecitabine in patients with carcinoma of unknown primary site. Cancer. 2007;110:770-775. 435. Schoemaker D, Black R, Giles L, Toouli J. Yearly colonoscopy, liver CT, and chest radiography do not influence 5-year survival of colorectal cancer patients. Gastroenterology. 1998;114:7-14.